Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Pharmaceutics|July 2, 2021
ChoK-Full of Potential: Choline Kinase in B Cell and T Cell MalignanciesSamantha Gokhale, Ping XieFrontiers in Oncology|February 13, 2023
TRAF3: A novel regulator of mitochondrial physiology and metabolic pathways in B lymphocytesJaeyong Jung, Samantha Gokhale, Ping XieDermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 28, 2024
Mitigating Immunogenicity by Coordinating Botulinum Toxin Treatments Between Aesthetics and TherapeuticsStephen M Gollomp, Saami Khalifian, Samantha GokhaleCurrent Pharmacology Reports|March 13, 2018
TRAF molecules in inflammation and inflammatory diseasesAlmin I Lalani, Sining Zhu, Samantha Gokhale, et al.Frontiers in Oncology|November 15, 2021
Clinical Trials of the BTK Inhibitors Ibrutinib and Acalabrutinib in Human Diseases Beyond B Cell MalignanciesSining Zhu, Jaeyong Jung, Eton Victor, et al.Frontiers in Immunology|October 9, 2018
Genetic Alterations of TRAF Proteins in Human CancersSining Zhu, Juan Jin, Samantha Gokhale, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2019
Elevated Choline Kinase α-Mediated Choline Metabolism Supports the Prolonged Survival of TRAF3-Deficient B LymphocytesSamantha Gokhale, Wenyun Lu, Sining Zhu, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2023
Upregulated Expression of the IL-9 Receptor on TRAF3-Deficient B Lymphocytes Confers Ig Isotype Switching Responsiveness to IL-9 in the Presence of Antigen Receptor Engagement and IL-4Samantha Gokhale, Eton Victor, Jemmie Tsai, et al.Frontiers in Cell and Developmental Biology|September 6, 2021
Multifaceted Immunomodulatory Effects of the BTK Inhibitors Ibrutinib and Acalabrutinib on Different Immune Cell Subsets - Beyond B LymphocytesSining Zhu, Samantha Gokhale, Jaeyong Jung, et al.Molecular Vision|May 4, 2017
The MicroRNA-21 signaling pathway is involved in prorenin receptor (PRR) -induced VEGF expression in ARPE-19 cells under a hyperglycemic conditionRashidul Haque, P Michael Iuvone, Li He, et al.Pageof 2